First post here on HotCopper as I was a quiet reader over the last few years...
I totally agree Vivo. Efti will be a blockbuster and big Pharma won't let that slip through their fingers. Especially Merck with Keytruda patent expiring 2028 and the chance to extend it. I was working for one big Pharma player and there is nothing worse than a drug becoming generic. Just look at Pfizer selling their generic drug business 2019. Sales dropped tremendously. I don't think Merck will let that happen to Keytruda.
What is the timeline for AIPAC and TACTI-003 in 2022?
First post here on HotCopper as I was a quiet reader over the...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.025(5.15%) |
Mkt cap ! $552.8M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 47.0¢ | 45.5¢ | $823.8K | 1.790M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 120010 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 73770 | 22 |
View Market Depth
| Last trade - 13.11pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
46.0¢ |
Change
-0.025 ( 4.19 %) |
||||
| Open | High | Low | Volume | ||
| 47.5¢ | 47.5¢ | 45.8¢ | 564915 | ||
| Last updated 13.08pm 08/05/2024 ? | |||||
| IMM (ASX) Chart |